(lp0
S'Bioptix Announces Executive Leadership Change PR Newswire  - Apr 10, 2017 CASTLE ROCK, Colo., April 10, 2017 /PRNewswire/ -- Bioptix, Inc.  , announced that its board of directors has appointed Michael M. Beeghley as chief executive officer effective as of April 6, 2017.Bioptix, Inc  Names Michael M. Beeghley as CEO - StreetInsider.com'
p1
aS"Bioptix Reports Board of Director Changes PR Newswire  - Jan 6, 2017 BOULDER, Colo., Jan. 6, 2017 /PRNewswire/ -- Bioptix, Inc. , , announced that Gail Schoettler, Susan Evans and David Welch have resigned from the Company's Board of Directors."
p2
aS'4.13 MarketWatch - Jan 6, 2017 Bioptix Inc. BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult ...'
p3
aS'Bioptix Announces Streamlining of Workforce PR Newswire  - Jan 20, 2017 20, 2017 /PRNewswire/ -- Bioptix, Inc.  , announced that on January 14, 2017 the Board of Directors of the Company adopted a plan under which the Company will terminate certain employees associated with the&nbsp;...'
p4
aS"Form 8-K Bioptix, Inc. For: Apr 10 StreetInsider.com - Apr 13, 2017 On April 10, 2017, Bioptix, Inc.  received a notice of deficiency from The Nasdaq Stock Market  indicating that the Company is not in compliance with Nasdaq's audit committee requirements as set forth in Nasdaq Listing Rule 5605."
p5
aS'Venaxis Announces Acquisition of BiOptix PR Newswire  - Sep 13, 2016 13, 2016 /PRNewswire/ -- Venaxis, Inc. , announced today that it has acquired BiOptix Diagnostics, Inc.,  a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance&nbsp;...'
p6
aS"BRIEF-Bioptix Inc files for mixed shelf offering of up to $20 million - SEC filing Reuters - Feb 8, 2017 WASHINGTON, March 24 After failing to repeal Obamacare, Republicans in the U.S. Congress quickly pivoted on Friday to President Donald Trump's next priority: overhauling the federal tax code, but their plan has already split the business community."
p7
aS'Honig Is Buying Again: This Time, Bioptix Inc.  Small Cap Exclusive  - Jan 5, 2017 In a just published Form 13, filed with the US Securities and Exchange Commission , Bioptix Inc.  reported that Honig Barry C. has picked up 504,000 of common stock as of 2017-01-05.'
p8
aS"Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to ... PR Newswire  - Dec 8, 2016 BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ -- Venaxis, Inc. , announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change the Company's name, the Company's name has&nbsp;...Venaxis  Changes Name to Bioptix; Will Trade Under Ticker 'BIOP' - StreetInsider.com"
p9
aS'Bioptix names new CEO, receives notice of noncompliance from Nasdaq BizWest Media - Apr 14, 2017 CASTLE ROCK - Bioptix Inc.  has a new CEO, with Michael M. Beeghley replacing Steve Lundy as CEO. Lundy resigned from his role as president, CEO and member of the board of directors on April 6. Beeghley will serve as chairman of the&nbsp;...'
p10
a.